Question

Difficulty: HardGastroenterology and Hepatology

A 45-year-old man is hospitalized due to severe acute pancreatitis secondary to alcohol use. He is admitted to the intensive care unit and managed with aggressive intravenous fluid resuscitation, analgesia, and enteral nutrition. On day 3 of hospitalization, the patient develops a temperature of 38.8∘C38.8^{\circ}\text{C} (101.8∘F101.8^{\circ}\text{F}). His blood pressure is 112/70 mmHg112/70\text{ mmHg}, pulse is 114/min114\text{/min}, and respirations are 22/min22\text{/min}. Physical examination shows a distended abdomen with severe epigastric tenderness but no rebound or guarding.

Laboratory studies show a leukocyte count of 18,500/mm318,500/\text{mm}^3 and a serum lipase of 1,200 U/L1,200\text{ U/L}. A contrast-enhanced CT scan of the abdomen reveals acute inflammation of the pancreas with a 6-cm6\text{-cm} area of non-enhancement in the pancreatic body and tail, consistent with >30%>30\% pancreatic necrosis. There is no gas observed within the necrotic collection. The gallbladder is surgically absent, and the biliary tree is not dilated. Blood, urine, and sputum cultures are obtained.

What is the most appropriate next step in management?

  1. A
    Initiate intravenous imipenem-cilastatin empirically
  2. B
    Perform urgent exploratory laparotomy with pancreatic necrosectomy
  3. C
    Perform endoscopic retrograde cholangiopancreatography (ERCP)
  4. Withhold antimicrobial therapy and continue supportive careAnswer
  5. E
    Initiate intravenous piperacillin-tazobactam for prophylaxis

Answer

The most appropriate next step is to withhold antimicrobial therapy and continue supportive care.
In the early phase (specifically the first week) of severe acute pancreatitis, the development of fever, tachycardia, and leukocytosis is typically secondary to the systemic inflammatory response syndrome (SIRS) driven by massive cytokine release, rather than an active bacterial infection. Current gastroenterology guidelines strongly recommend against the routine use of prophylactic antibiotics for sterile pancreatic necrosis. Studies have shown that prophylactic antibiotics do not reduce mortality or the incidence of infected necrosis; instead, they increase the risk of opportunistic fungal infections and multi-drug resistant organisms. Infection of necrotic tissue usually occurs 77 to 1010 days after initial presentation and should be suspected when a patient clinically deteriorates after initial improvement, or when a CT scan demonstrates gas bubbles within the fluid collection.

Step-by-Step Solution

1
Analyze the timing of the patient's symptoms relative to disease onset.
The patient is on day 3 of severe acute pancreatitis with new-onset fever and leukocytosis.
Timing helps distinguish between Systemic Inflammatory Response Syndrome (SIRS), which peaks in the first week, and infected necrosis, which typically occurs 7-10 days after presentation.
2
Evaluate imaging findings for signs of active infection or alternate pathologies.
CT shows sterile necrosis (no gas) and there is no evidence of biliary obstruction.
Infected necrosis (gas on CT) or concurrent acute cholangitis would warrant immediate antibiotic therapy and possible procedural intervention.
3
Apply evidence-based gastroenterology guidelines for sterile pancreatic necrosis.
Prophylactic antibiotics are withheld, and supportive care is continued.
Guidelines recommend against prophylactic antibiotics because they do not improve outcomes and select for resistant organisms and fungal superinfections.

Key Concept

Management of acute necrotizing pancreatitis and indications for antimicrobial therapy.
Estimated Time:1m 15s
Rate this question